Clay Smith, a CUI Inventor, was recently published in the journal Nature Cancer.
Article title: Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells
BridgeBio Pharma, Inc. and the University of Colorado Anschutz Medical Campus today announced a collaboration to advance novel research on genetically driven diseases into therapeutic applications for patients.